Indications
NexoBrid is indicated in all age groups for removal of eschar in patients with deep partial- and full-thickness thermal burns.
Composition
- Active substance
- proteolytic enzymes enriched in bromelain
- International name (INN)
- concentrate of proteolytic enzymes enriched in bromelain
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- NexoBrid
- Active substance
- proteolytic enzymes enriched in bromelain
- ATC code
- D03BA03
- Group
- Dermatologicals
- Therapeutic area
- Debridement
- Marketing authorisation holder
- MediWound Germany GmbH



